tiprankstipranks
Clarity Pharmaceuticals Ltd. (AU:CU6)
ASX:CU6
Australian Market

Clarity Pharmaceuticals Ltd. (CU6) Financial Statements

Compare
145 Followers

Clarity Pharmaceuticals Ltd. Financial Overview

Clarity Pharmaceuticals Ltd.'s market cap is currently AU$1.09B. The company's EPS TTM is AU$-0.154; its P/E ratio is ―; Clarity Pharmaceuticals Ltd. is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is AU$-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 11.51MAU$ 9.80MAU$ 6.46MAU$ 3.20MAU$ 2.79M
Gross ProfitAU$ 11.51MAU$ 9.70MAU$ 6.41MAU$ 3.18MAU$ 2.77M
Operating IncomeAU$ -44.80MAU$ -36.16MAU$ -30.29MAU$ -13.51MAU$ -9.85M
EBITDAAU$ -44.65MAU$ -26.26MAU$ -17.00MAU$ -10.30MAU$ -7.04M
Net IncomeAU$ -42.32MAU$ -24.60MAU$ -23.75MAU$ -10.22MAU$ -6.95M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 136.51MAU$ 65.01MAU$ 92.34MAU$ 18.94MAU$ 6.27M
Total AssetsAU$ 154.63MAU$ 76.90MAU$ 99.82MAU$ 22.61MAU$ 9.12M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -47.90MAU$ -65.01MAU$ -55.34MAU$ -8.44MAU$ -5.27M
Total LiabilitiesAU$ 8.33MAU$ 7.72MAU$ 7.59MAU$ 2.34MAU$ 956.09K
Stockholders' EquityAU$ 146.30MAU$ 69.18MAU$ 92.24MAU$ 20.28MAU$ 8.16M
Cash Flow
Free Cash FlowAU$ -43.74MAU$ -27.55MAU$ -13.53MAU$ -7.74MAU$ -6.84M
Operating Cash FlowAU$ -43.24MAU$ -27.50MAU$ -13.31MAU$ -7.68MAU$ -6.83M
Investing Cash FlowAU$ -55.31MAU$ 3.15MAU$ -26.71MAU$ -60.31KAU$ -14.50K
Financing Cash FlowAU$ 115.21MAU$ 231.58KAU$ 86.93MAU$ 10.91MAU$ 8.22M
Currency in AUD

Clarity Pharmaceuticals Ltd. Earnings and Revenue History

Clarity Pharmaceuticals Ltd. Debt to Assets

Clarity Pharmaceuticals Ltd. Cash Flow

Clarity Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis